News

Contact lenses that can capture and detect exosomes – vesicles with the potential to act as cancer biomarkers – could be used to screen for cancers.

Findings from a study suggest that positron emission tomography (PET) imaging could provide a widely accessible approach to measure the pharmacodynamic effects of using stimulator of interferon genes (STING)-activating drugs.

Researchers have identified a molecular pathway responsible for glioblastoma spreading within in the brain, and an existing drug that may curb tumor growth, leading to a clinical trial that could offer new hope to patients with glioblastoma.

A new study has highlighted the importance of annual mammogram screenings before age 50 for decreasing the incidence of advanced breast cancers.

A study has shown that active brain metastases in breast cancer patients can be regressed by a novel class of drug known as T-Dxd – a chemical conjugate of an antibody and a chemotherapy drug.

Collage is known to form a key part of the tumor microenvironment and new research has shown that it also triggers metastasis in breast cancer.

Researchers have used a zebrafish eye mutation to study the role of a protein in preventing cell death, which could have implications for the development of cancer therapies

An NMR method enhanced by a very powerful amplifier, in combination with molecular dynamics simulation, now enables protein detection and accurate characterization at physiological concentrations.

A collaborative research team has synthesized a molecule that could be used as an alternative to the antibodies used in immunotherapy treatment for cancer. The study is published in the Journal for ImmunoTherapy of Cancer.

Researchers have developed a powerful immunity-boosting postoperative hydrogel treatment that could improve the outlook for patients with glioblastoma.